CAC
RLMD icon

Cowen and Company’s Relmada Therapeutics RLMD Stock Holding History

Cowen and Company’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-64,011
Closed -$223K – 677
2022
Q4 		$223K Sell
64,011
-152,430
-70% -$1.34M 0.02% 168
2022
Q3 		$8.01M Sell
216,441
-850,413
-80% -$23.6M 0.77% 30
2022
Q2 		$20.3M Sell
1,066,854
-97,507
-8% -$2.13M 2% 13
2022
Q1 		$31.4M Buy
1,164,361
+1,014,587
+677% +$21M 3.17% 7
2021
Q4 		$3.37M Sell
149,774
-9,859
-6% -$219K 0.32% 65
2021
Q3 		$4.18M Hold
159,633
– – 0.2% 50
2021
Q2 		$5.11M Sell
159,633
-7,309
-4% -$254K 0.27% 42
2021
Q1 		$5.88M Buy
+166,942
New +$5.84M 0.41% 28

Other funds holding RLMD

DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return